Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Hypertension

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004872-200201000-00011PMID 11791028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of endothelial function in large and small arteries in human essential hypertension.

  2001cited by this paper
• Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis

  2001cited by this paper
• Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

  2001cited by this paper
• Clinical trials report

  2001cited by this paper
• Blood Pressure Control and Benefits of Antihypertensive Therapy: Does It Make a Difference Which Agents We Use?

  2001cited by this paper
• [Vascular remodeling].

  2000cited by this paper
• Differences between blood-pressure-lowering drugs.

  2000cited by this paper
• Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.

  2000cited by this paper
• Blockade of Angiotensin II Type 1 Receptors: Effect on Carotid and Radial Artery Structure and Function in Hypertensive Humans

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

  2000cited by this paper
• Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.

  2000cited by this paper
• Chronic NG-Nitro-l-Arginine Methyl Ester Treatment Does Not Prevent Flow-Induced Remodeling in Mesenteric Feed Arteries and Arcading Arterioles

  2000cited by this paper
• Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.

  2000cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.

  1999cited by this paper
• Mechanics and composition of human subcutaneous resistance arteries in essential hypertension.

  1999cited by this paper
• In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels.

  1999cited by this paper
• Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries.

  1999cited by this paper
• Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

  1998cited by this paper
• Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Effects of long‐term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.

  1997cited by this paper
• Vascular remodeling.

  1996cited by this paper
• Angiotensin II type 2 receptor mediates programmed cell death.

  1996cited by this paper
• Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonist

  1996cited by this paper
• The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension.

  1995cited by this paper
• Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.

  1995cited by this paper
• Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.

  1995cited by this paper
• In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy.

  1995cited by this paper
• Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

  1995cited by this paper
• Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

  1994cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper
• Preserved endothelium-dependent vasodilatation in patients with essential hypertension.

  1994cited by this paper
• Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.

  1993cited by this paper
• Histology of subcutaneous small arteries from patients with essential hypertension.

  1993cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

  1992cited by this paper
• Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

  1991cited by this paper
• Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

  1990cited by this paper
• Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

  1990cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

  1990cited by this paper
• Angiotensin II Induces Hypertrophy, not Hyperplasia, of Cultured Rat Aortic Smooth Muscle Cells

  1988cited by this paper
• Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives.

  1987cited by this paper
• The Australian Therapeutic Trial in Mild Hypertension.

  1987cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• Coeliac lung disease.

  1978cited by this paper
• Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

  1970cited by this paper

• The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis

  2024cites this paper
• The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19

  2022cites this paper
• Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS

  2022cites this paper
• Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods

  2021cites this paper
• Harnessing polyphenol power by targeting eNOS for vascular diseases

  2021cites this paper
• Microvascular Alterations in Diabetes: Focus on Small Resistance Arteries

  2020cites this paper
• Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19

  2020cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• Pharmacogenetic Implications of eNOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy

  2019cites this paper
• Endothelial dysfunction complications and current status

  2019cites this paper
• Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

  2019cites this paper
• Determinant Factors for Arterial Hemodynamics in Hypertension: Theoretical Insights From a Computational Model-Based Study.

  2018influential citation
• Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

  2018cites this paper
• Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension.

  2017cites this paper
• Effects of carotid baroreceptor stimulation on retinal arteriole remodeling evaluated with adaptive optics camera in resistant hypertensive patients.

  2017cites this paper
• A STUDY SHOWING THE EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

  2016cites this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cites this paper
• Role of Vascular Endothelium in Hypertension, Atherosclerosis and Peripheral Arterial Disease

  2016cites this paper
• Irbesartan attenuates TNF-α-induced ICAM-1, VCAM-1, and E-selectin expression through suppression of NF-κB pathway in HUVECs.

  2015cites this paper
• Mechanisms of remodelling of small arteries, antihypertensive therapy and the immune system in hypertension.

  2015influential citation
• Elastin Organization in Pig and Cardiovascular Disease Patients' Pericardial Resistance Arteries

  2015cites this paper
• The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure

  2014cites this paper
• The Renin-Angiotensin System, Capri 2005

  2013cites this paper
• Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study

  2013cites this paper
• Endothelial protective activity of boldine in animal models of hypertension and diabetes mellitus / Lau Yeh Siang

  2013cites this paper
• Endothelium-dependent relaxations in the aorta from K(2p)6.1 knockout mice.

  2013cites this paper
• The Vascular Endothelium and Human Diseases

  2013cites this paper
• Excellence Award in Hypertension Research Vascular Remodeling in Hypertension Mechanisms and Treatment

  2012cites this paper
• Evaluation of pharmacological properties of Danshen compounds by computational and biochemical approaches

  2012cites this paper
• Dissociation of blood pressure and resistance artery structure: potential clinical implications.

  2012cites this paper
• Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.

  2012cites this paper
• Effect of treatment on cardiac small resistance arteries in hypertension and diabetes: trick or treat.

  2012cites this paper
• Hypertension and endothelial dysfunction: therapeutic approach.

  2012cites this paper
• Vascular Remodeling in Hypertension: Mechanisms and Treatment

  2012cites this paper
• Ultrasound and radiology surrogate endpoints in pharmacological studies.

  2012cites this paper
• Étude de la protection vasculaire par l’angiotensine IV : rôle dans le diabète et le traumatisme crânien

  2011cites this paper
• The Role of Beta-Blockers as First-Line Therapy in Hypertension

  2011cites this paper
• The Renin-Angiotensin Axis Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

  2011cites this paper
• Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease.

  2011cites this paper
• Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature

  2010cites this paper
• Diagnosis and Treatment of Endothelial Dysfunction in Cardiovascular Disease A Review

  2010cites this paper
• Change in Augmentation Index during NOS Inhibition, an Index of Basal NO Production, Is an Independent Determinant of Large-Artery Function

  2010cites this paper
• Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

  2010cites this paper
• Diagnosis and treatment of endothelial dysfunction in cardiovascular disease.

  2010cites this paper
• Vascular Endothelin and Angiotensin Receptors Regulation in Inflammatory Arterial Disorders

  2010cites this paper
• Why beta-blockers should not be used as first choice in uncomplicated hypertension.

  2010cites this paper
• Vascular Effects of Antihypertensive Drug Therapy

  2010cites this paper
• Protective effects of renin–angiotensin blockade beyond blood pressure control

  2009cites this paper
• Effects of antihypertensive treatment on small artery remodelling

  2009cites this paper
• The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition

  2009cites this paper
• Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients

  2008cites this paper
• Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

  2008cites this paper
• Dysfunkcja śródbłonka i ADMA w patogenezie nadciśnienia tętniczego Endothelial dysfunction and ADMA in pathogenesis of arterial hypertension

  2008cites this paper
• Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors.

  2008cites this paper
• Review: New techniques for assessment of vascular function

  2008cites this paper
• Highlights from International Congress

  2008cites this paper
• Small artery remodelling in hypertension: causes, consequences and therapeutic implications

  2008cites this paper
• Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.

  2008cites this paper
• Vascular endothelial function in health and diseases.

  2008cites this paper
• Pharmacologic considerations in the positioning of β-blockers in antihypertensive therapy

  2008cites this paper
• Hypertension and microvascular remodelling.

  2008cites this paper
• A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension.

  2008cites this paper
• Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?

  2007cites this paper
• Large and small artery endothelial function in patients with essential hypertension – Effect of ACE inhibition and beta‐blockade

  2007cites this paper
• Vascular benefits of angiotensin receptor blockers

  2007cites this paper
• Small artery stucture adapts to vasodilatation rather than to blood pressure during antihypertensive treatment

  2007cites this paper
• Cardiovascular protection using beta-blockers: a critical review of the evidence.

  2007cites this paper
• Angiotensin II Receptor Antagonists Supplementation is Associated with Arterial Stiffness: Insight from a Retrospective Study in 116 Peritoneal Dialysis Patients

  2007cites this paper
• Review: Pharmacological and non-pharmacological treatment of endothelial dysfunction: relevance to diabetes:

  2007cites this paper
• Chapter 47 – The Effects of Hypertension on the Structure of Human Resistance Vessels

  2007cites this paper
• 10.12 The Ambulatory Arterial Stiffness Index is Associated with Capillary Rarefaction

  2007cites this paper
• A Critical Review of the Evidence

  2007cites this paper
• Angiotensin Receptor Blocker Added to Previous Antihypertensive Agents on Arteries of Diabetic Hypertensive Patients

  2006cites this paper
• Angiotensin Receptor Blockers: New Considerations in Their Mechanism of Action

  2006cites this paper
• Small artery remodeling in hypertension and diabetes

  2006cites this paper
• Leaking Capillaries and White Lung in Sepsis—Is Angiopoietin 2 the Culprit? Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans. PLoS Medicine 3: e46, 2006

  2006cites this paper
• Remodelling of Small Resistance Arteries in Essential Hypertension

  2006cites this paper
• Nephrology beyond JASN

  2006cites this paper
• Angiotensin II antagonists and protection against subclinical cardiac and vascular damage

  2006cites this paper
• Should atenolol still be recommended as first-line therapy for primary hypertension?

  2006cites this paper
• Effect of candesartan on coronary flow reserve in patients with systemic hypertension

  2006cites this paper
• EFECTOS CARDIOVASCULARES DE ISOFLAVONAS EN HIPERTENSIÓN GENÉTICA

  2006cites this paper
• Inhibition of the renin angiotensin system: Implications for the endothelium

  2006cites this paper
• Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients.

  2006cites this paper
• Características farmacológicas de los ARA-II. ¿Son todos iguales?

  2006cites this paper
• Angiotensin, bradykinin and the endothelium.

  2006cites this paper
• Effect of Nebivolol on Endothelial Nitric Oxide and Peroxynitrite Release in Hypertensive Animals: Role of Antioxidant Activity

  2006cites this paper
• Clinical methods for the evaluation of endothelial function – a focus on resistance arteries

  2006cites this paper
• Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study

  2006cites this paper
• The VALUE Trial

  2005cites this paper
• Peripheral resistance Hypertension Volume expansion Sodium chloride reabsorption Sympathetic activation Leptin Renin-angiotensin activation Obesity

  2005cites this paper
• Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus

  2005cites this paper
• Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery

  2005cites this paper
• Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy

  2005cites this paper
• Obesity hypertension: the rationale for renin-angiotensin system blockade.

  2005cites this paper
• Endothelial dysfunction: its role in hypertensive coronary disease

  2005cites this paper
• Renin-Angiotensin Inhibitors and Vascular Effects

  2004cites this paper
• Intervención sobre el sistema renina-angiotensina para la protección vascular del paciente hipertenso y en la nefropatía diabética

  2004cites this paper
• Renin–Angiotensin System as a Therapeutic Target in Managing Atherosclerosis

  2004cites this paper
• Different effects of antihypertensive drugs on endothelial dysfunction

  2004cites this paper